ReviewProgress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
Section snippets
Adenosine-Releasing Silk
D. Boison
Robert Stone Dow Neurobiology Labs, Legacy Research Institute, Portland, OR, USA
Allopregnanolone (SAGE-547) Injection
S.J. Kanes1, J. Doherty1, R. Hammond1, M.A. Rogawski2, A. Robichaud1, J. Jonas1
1 Sage Therapeutics, Cambridge, MA 02142, USA2 Department of Neurology, University of California, Davis, Sacramento, CA 95817, USA
AMP-X-0079
A. Pesyan1, R.J. Porter2
1 AurimMed Pharma, Park City, Utah, USA2 University of Pennsylvania, Philadelphia, PA, USA, and USUHS, Bethesda, MD, USA
Brivaracetam (UCB 34714)
J. D'Souza1, H. Klitgaard2, A. Stockis3, J. Whitesides4
1UCB Pharma, Smyrna, GA, USA2UCB Pharma, Brussels, Belgium; 3UCB Pharma, Braine-L’Alleud, Belgium; 4UCB Pharma, Raleigh, NC, USA
Bumetanide
R.M. Pressler
Section of Clinical Neurosciences Unit, Institute of Child Health, University College London, UK
Cannabidiol
S. Wright1, K. Sommerville1+, N.A. Jones1, B.J. Whalley2
1 GW Pharma GW Research Limited, Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, UK1+ GW Pharmaceuticals and Duke University Medical School, UK2 Reading School of Pharmacy, University of Reading, Whiteknights, Reading, Berkshire RG6 6AP, UK
Cannabidivarin (GWP 420006)
N.A. Jones1, B.J. Whalley2
1 GW Pharma GW Pharmaceuticals plc, Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, UK2 Reading School of Pharmacy, University of Reading, Whiteknights, Reading, Berkshire, UK
2-Deoxy-d-glucose
T. Sutula
Department of Neurology, University of Wisconsin, Madison, WI, USA and NeuroGenomeX, Inc., Madison, WI, USA
Everolimus
P. Curatolo
Systems Medicine Department, Child Neurology and Psychiatry Unit, Tor Vergata University Hospital of Rome, Italy
Ganaxolone
G. Farfela, J. Tsaia, V. Nohriab
a Marinus Pharmaceuticals, Inc., New Haven, CT, USAb Mercer University, Atlanta, GA, USA
Huperzine A
S.D. Collins, J.T. Johnstone, S.S. Schachter
Insero Health, Inc., USA
Imepitoin
W. Löscher
Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine, Hannover, Germany
Minocyciline
S. Koh
Department of Pediatrics, Ann & Robert H. Lurie, Children's Hospital of Chicago, Neurobiology Program, Stanley Manne Children's Research Institute, Northwestern University, Feinberg School of Medicine, Chicago, IL 60614, USA
NAX 810-2
H.S. Whitea,c, G. Bulajb, B.D. Kleina,c, C.S. Metcalfc, D.R. McDouglec, M.D. Smitha, L. Zhangb
a Department of Pharmacology and Toxicologyb Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, UT, United States; c Neuroadjuvants, Inc., Salt Lake City, UT, United States
Pitolisant (Tripolisant)
D. Kasteleijn-Nolst Trenité
University of Utrecht, The Netherlands; University Sapienza, Rome, Italy
PRX 0023 (Nalutozan)
W.H. Theodore
Clinical Epilepsy Section, National Institutes of Health, Building 10, Room 7D-43, Bethesda, MD 20892, USA
SAGE-217
A.J. Robichaud, J.J. Doherty, S.J. Kanes, G.J. Belfort, M.A. Ackley, E.C. Hoffman, R.S. Hammond, G. Martinez Botella, F.G. Salituro, J.M. Jonas
Sage Therapeutics, Cambridge, MA 02142, USA
Valnoctamide and sec-butyl-propylacetamide (SPD): Second generation drugs to valproic acid (VPA)
M. Bialer1, S. Kadosh2, B. Yagen1
1 Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel2 StatExcellence, Kfar Saba, Israel
VLB-01 (Beprodone)
M. Toumi1, A. Bakhutashvili2, A. Miller3
1 Faculte’ de Medicine, Laboratoire De Sante’ Publique, Aix Marseille Universite, Universite De La Mediterranee, Marseille, France2 Chief Scientific Officer, Marco Polo, Luxembourg3 Health Economics and Outcomes Research, Creativ Ceutical, Paris, France
YKP3089
S.J. Lee, M. Kamin, P. Ilankumaran
SK Life Science Inc., Fair Lawn, NJ, USA
References (221)
- et al.
Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures
Neurobiol. Dis.
(2012) - et al.
Glial adenosine kinase – a neuropathological marker of the epileptic brain
Neurochem. Int.
(2013) - et al.
The effect of minocycline on seizures induced by amygdala kindling in rats
Seizure
(2013) - et al.
Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one
Eur. J. Pharmacol.
(1989) Chemical properties of antiepileptic drugs (AEDs)
Adv. Drug Deliv. Rev.
(2012)- et al.
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)
Epilepsy Res.
(2010) - et al.
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Epilepsy Res.
(1999) - et al.
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
Epilepsy Res.
(2001) - et al.
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
Epilepsy Res.
(2013) - et al.
Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)
Epilepsy Res.
(2009)